1. Home
  2. QFIN vs CYTK Comparison

QFIN vs CYTK Comparison

Compare QFIN & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QFIN
  • CYTK
  • Stock Information
  • Founded
  • QFIN 2016
  • CYTK 1997
  • Country
  • QFIN China
  • CYTK United States
  • Employees
  • QFIN N/A
  • CYTK N/A
  • Industry
  • QFIN Finance: Consumer Services
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • QFIN Finance
  • CYTK Health Care
  • Exchange
  • QFIN Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • QFIN 5.0B
  • CYTK 5.6B
  • IPO Year
  • QFIN 2018
  • CYTK 2004
  • Fundamental
  • Price
  • QFIN $41.10
  • CYTK $31.02
  • Analyst Decision
  • QFIN Strong Buy
  • CYTK Buy
  • Analyst Count
  • QFIN 2
  • CYTK 15
  • Target Price
  • QFIN $45.10
  • CYTK $73.71
  • AVG Volume (30 Days)
  • QFIN 1.5M
  • CYTK 2.4M
  • Earning Date
  • QFIN 05-19-2025
  • CYTK 05-06-2025
  • Dividend Yield
  • QFIN 3.11%
  • CYTK N/A
  • EPS Growth
  • QFIN 68.59
  • CYTK N/A
  • EPS
  • QFIN 6.45
  • CYTK N/A
  • Revenue
  • QFIN $2,439,629,299.00
  • CYTK $19,218,000.00
  • Revenue This Year
  • QFIN $8.44
  • CYTK $24.01
  • Revenue Next Year
  • QFIN $7.34
  • CYTK $698.33
  • P/E Ratio
  • QFIN $6.38
  • CYTK N/A
  • Revenue Growth
  • QFIN 5.10
  • CYTK 412.21
  • 52 Week Low
  • QFIN $18.13
  • CYTK $29.31
  • 52 Week High
  • QFIN $48.94
  • CYTK $61.38
  • Technical
  • Relative Strength Index (RSI)
  • QFIN 43.39
  • CYTK 39.05
  • Support Level
  • QFIN $41.79
  • CYTK $30.02
  • Resistance Level
  • QFIN $43.21
  • CYTK $31.27
  • Average True Range (ATR)
  • QFIN 1.58
  • CYTK 1.40
  • MACD
  • QFIN -0.35
  • CYTK 0.24
  • Stochastic Oscillator
  • QFIN 9.79
  • CYTK 42.12

About QFIN Qifu Technology Inc.

Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: